Glanzmann’s Thrombasthenia During Pregnancy: Case Report and Literature Review

Abstract

Glanzmann's thrombasthenia is an uncommon congenital disease due to an anomaly qualitative or quantitative of the glycoprotein complex GPIIb / IIIA with the consequence of a defective platelet aggregation. Hemorrhages in pregnant women with this bleeding disorder can be severe and may require aggressive treatment with a combined therapy including platelet concentrates, anti-brinolytics and rFVIIa. A scheduled plan for obstetric and haematological management should be set in advance.Close clinical observation, laboratory monitoring and immediate access to pro-haemostatic therapies are essential, leading to lower rates of postpartum hemorrhage.A 35 year-old white woman with Glanzmann's thrombasthenia was followed during pregnancy. A multidisciplinary meeting including gynaecologists, obstetrics, haematologists and anaesthesiologists was arranged for the management of unexpected antepartum haemorrhages, method of delivery and postpartum care.The primary aim of this case report was to evaluate the management of thrombasthenia of Glanzmann during pregnancy, with particular emphasis on the current management of the hemorrhages and the method of delivery, in order to ensure optimal maternal and fetal outcomes.